Pyoderma gangrenosum in an allogeneic bone marrow transplant recipient

Area of Science:

• Dermatology
• Hematology
• Immunology

Background:

• Allogeneic bone marrow transplantation is a curative therapy for hematologic malignancies.
• Chronic myelogenous leukemia (CML) can present with a 'blast' crisis, necessitating intensive treatment.
• Pyoderma gangrenosum (PG) is a rare, ulcerative neutrophilic dermatosis with various potential triggers.

Observation:

• A 15-year-old male developed facial pyoderma gangrenosum 7 months after allogeneic bone marrow transplantation for CML blast crisis.
• The patient had no clinical or laboratory evidence of leukemia relapse at the time of PG onset.
• The facial lesions presented as rapidly progressing, painful ulcers.

Findings:

• This case highlights an unusual presentation of pyoderma gangrenosum in the context of post-bone marrow transplant immunosuppression.
• The temporal association suggests a potential role for altered immune status in PG development.
• The occurrence of PG preceding leukemia relapse warrants further investigation into immune dysregulation.

Implications:

• Understanding the pathogenesis of pyoderma gangrenosum in immunocompromised patients is crucial for timely diagnosis and management.
• This case underscores the importance of considering non-relapse-related complications following bone marrow transplantation.
• Further research into the link between myeloproliferative disorders, immunosuppression, and pyoderma gangrenosum may reveal novel therapeutic targets.